Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

  • Fulltext

    Final published version, 812 KB, PDF document

  • David A. Lipson
  • Courtney Crim
  • Gerard J. Criner
  • Nicola C. Day
  • Mark T. Dransfield
  • David M. G. Halpin
  • MeiLan K. Han
  • C. Elaine Jones
  • Sally Kilbride
  • Lange, Peter
  • David A. Lomas
  • Sally Lettis
  • Pamela Manchester
  • Neil Martin
  • Dawn Midwinter
  • Andrea Morris
  • Steven J. Pascoe
  • Dave Singh
  • Robert A. Wise
  • Fernando J. Martinez
Original languageEnglish
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume201
Issue number12
Pages (from-to)1508-1516
Number of pages9
ISSN1073-449X
DOIs
Publication statusPublished - 2020

    Research areas

  • COPD, triple therapy, mortality, survival

ID: 244232417